InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,894.39
(
0.40%
)
US TECH 100
20,046.40
(
0.92%
)
Dow Jones
43,421.78
(
-0.05%
)
Brent Oil
72.73
(
2.86%
)
Bitcoin
92,440.54
(
2.83%
)

Replies to post #77103 on Biotech Values

Replies to #77103 on Biotech Values
icon url

DewDiligence

05/02/09 9:34 AM

#77108 RE: rkrw #77103

The COGS per patient will be much higher than $7,500 in the first few years, IMO—probably closer to $15K. At $15K, it is all but impossible for the product to enjoy a typical biopharmaceutical gross margin of 85%-95%.